CTOs on the Move

Proteogenomics Research Institute for Systems Me

www.prism-sd.org

 
Proteogenomics Research Institute for Systems Medicine (PRISM) is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Lansinoh Laboratories Inc

Lansinoh Laboratories Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Alexandria, VA. To find more information about Lansinoh Laboratories Inc, please visit www.lansinoh.com

St. Rita's Medical Center

St. Rita's Medical Center is a Lima, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cole Harbour Place

Cole Harbour Place is a Dartmouth, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shasta Regional Medical Center

Shasta Regional Medical Center is a 226-bed acute care, medical and surgical facility with a full range of ancillary services. We have been serving far Northern California since 1945. Our hospital has a highly efficient and expanded Emergency Department with minimal patient wait times, a technologically advanced cardiac cath lab available 24/7, an accredited Stroke Team and digital (filmless) radiology services. We have more than 600 registered nurses, technicians, and support personnel working alongside more than 300 physicians on staff. Together, our staff is committed to combining the latest proven technology with personal care and attention to help our patients get better.

StemCells

StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.